MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 54 filers reported holding MARKER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $321 | +154.8% | 70,700 | +73.7% | 0.09% | +164.7% |
| Q2 2023 | $126 | +334.5% | 40,700 | 0.0% | 0.03% | +325.0% |
| Q1 2023 | $29 | -100.0% | 40,700 | -85.4% | 0.01% | -74.2% |
| Q3 2022 | $103,000 | +12.0% | 279,000 | 0.0% | 0.03% | +19.2% |
| Q2 2022 | $92,000 | -25.2% | 279,000 | 0.0% | 0.03% | -16.1% |
| Q1 2022 | $123,000 | +80.9% | 279,000 | +290.2% | 0.03% | +82.4% |
| Q4 2021 | $68,000 | -85.6% | 71,500 | -74.4% | 0.02% | -87.1% |
| Q3 2021 | $472,000 | -39.6% | 279,000 | -0.4% | 0.13% | -39.4% |
| Q2 2021 | $781,000 | – | 280,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |